3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
96
Rectal Neoplasms
42
Colonic Neoplasms
38
Stomach Neoplasms
31
Pancreatic Neoplasms
31
Neoplasm Metastasis
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Neoplasms
21
Esophageal Neoplasms
19
Burkitt Lymphoma
15
Adenocarcinoma Of Esophagus
14
Lymphoma
13
Leukemia
8
Adenocarcinoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Osteosarcoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Leukemia, Biphenotypic, Acute
4
Gastrointestinal Neoplasms
4
Gallbladder Neoplasms
4
Carcinoma, Hepatocellular
4
Liver Neoplasms
3
Intestinal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Bile Duct Neoplasms
3
Somatostatinoma
2
Interventions
pembrolizumab
26
atezolizumab
14
Nivolumab
13
Gemcitabine
13
Cisplatin
10
Docetaxel
8
Carboplatin
8
avelumab
7
Mitomycin
7
epacadostat
4
cabozantinib
4
Ipilimumab
4
pemigatinib
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
vofatamab
2
rucaparib
2
lenvatinib
2
enfortumab vedotin
2
durvalumab
2
cabazitaxel
2
bempegaldesleukin
2
Standard of Care
2
Rogaratinib
2
Ramucirumab
2
Radiation
2
Platinum
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Transitional Cell
×
Leucovorin
×
Clear all
No trials found.